Epidemiology of Hepatitis Delta Virus (HDV) Infection in the Dialysis Population

Taylor J.M. Genetic organization and replication strategy of hepatitis delta virus. Semin Virol 1993; 4: 313–7.

Rizzetto M. , Verme G. , Recchia S. . Chronic hepatitis in carriers of hepatitis B surface antigen with intrahepatic expression of the delta antigen: an active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983; 98: 437–41.

Smedile A. , Rizzetto M. Orthotopic liver transplantation for chronic viral hepatitis: an overview. Int J Clin Lab Res 1992; 22: 211–5.

Wright T.L. , Pereira B. Liver transplantation for chronic viral hepatitis. Liver Transplant Surg 1995; 1: 30–42.

Martin P. , Friedman L.S. Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 1995; 47: 1231–41.

Fabrizi F. , Martin P. Hepatitis in kidney transplantation. In: Danovitch G.M. , ed. Handbook of kidney transplantation. (3rd ed). Philadelphia: Lippincott Williams & Wilkins, 2001; 263–71.

Fabrizi F. , Martin P. , Lunghi G. , Ponticelli C. Novel evidence on hepatitis B virus infection in dialysis. Int J Artif Organs 2001; 24: 8–16.

Lewis-Ximenez L.L. , Oliveira J.M. , Mercadante L.A.C. , de Castro L. , Santa Catharina W. , Stuver S. , Yoshida C.F.T. Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron 2001; 87: 19–26.

Hutin Y.J.F. , Goldstein S.T. , Varma J.K. . An outbreak of hospital-acquired hepatitis B virus infection among patients receiving chronic hemodialysis. Infect Control Hosp Epidemiol 1999; 20: 731–5.

Rizzetto M. , Canese M.G. , Aricò S. . Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977; 18: 997–1003.

Rizzetto M. , Shih J.W.K. , Gerin J.L. Characterization of the hepatitis B virus (HBV)-associated δ antigen (δ Ag): incidence of anti- δ in HBsAg carriers by a solid-phase radioimmunoassay (SPRIA). Fed Proc 1979; 38: 1072.

Rizzetto M. The delta agent. Hepatology 1983; 3: 729–37.

Rizzetto M. , Canese M.G. , Gerin J.L. , London W.T. , Sly D.I. , Purcell R.H. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis 1980; 141: 590–602.

Hoyer W. , Bonino F. , Ponzetto A. Properties of delta associated ribonucleic acid. In: Verme G. , Bonino F. , Rizzetto M. , eds. Viral hepatitis and delta infection (Progress in clinical and biological research). New York: Alan R. Liss, Inc., 1983; 91–7.

Rizzetto M. , Purcell R.H. , Gerin J.L. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet 1980; 1: 8180: 1215–9.

Smedile A. , Rizzetto M. , Gerin J.L. Advances in hepatitis D virus biology and disease. Prog Liver Dis 1994; 12: 157–75.

Rizzetto M. , Hoyer B. , Canese M.G. . Delta antigen: the association of delta antigen with hepatitis B surface antigen and ribonucleic acid in the serum of delta infected chimpanzees. Proc Natl Acad Sci USA 1980; 77: 6124–8.

Bonino F. , Hoyer B. , Ford E. . The δ agent: HBsAg particles with δ antigen and RNA in the serum of an HBV carrier. Hepatology 1981; 1: 127–31.

Wu J.C. , Chen P.J. , Kuo M.Y. , Lee S.D. , Chen D.S. , Ting L.P. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol 1991; 65: 1095–104.

Ryu W.S. , Bayer M. , Taylor J. Assembly of hepatitis delta virus particles. J Virol 1992; 66: 2310–5.

Sureau C. , Moriarty A.M. , Thornton G.B. , Lanford R.E. Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens. J Virol 1992; 66: 1241–5.

Ottobrelli A. , Marzano A. , Smedile A. . Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991; 101: 1649–55.

Lau D.T.Y. , Doo E. , Park Y. , Kleiner D.E. , Schmid D. , Kuhns M.C. , Hoofnagle J.H. Lamivudine for chronic delta hepatitis. Hepatology 1999; 30: 546–9.

Smedile A. , Casey J.L. , Cote P.J. . Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology 1998; 27: 1723–9.

Netter H.J. , Kajino K. , Taylor J.M. Experimental transmission of human hepatitis delta virus to the laboratory mouse. J Virol 1993; 67: 3357–62.

Netter H.J. , Gerin J.L. , Tennant B.C. , Taylor J.M. Apparent helper-independent infection of woodchucks by hepatitis delta virus and subsequent rescue with woodchuck hepatitis virus. J Virol 1994; 68: 5344–50.

Rizzetto M. , Verme G. Delta hepatitis- present status. J Hepatol 1985; 1: 187–93.

Niro G.A. , Casey J.L. , Gravinese E. . Intrafamiliar transmission of hepatitis delta virus: molecular evidence. J Hepatol 1999; 30: 564–9.

Ponzetto A. , Hoyer B.P. , Popper H. , Engle R. , Purcell R.H. , Gerin J.L. Titration of the infectivity of hepatitis D virus in chimpanzees. J Infect Dis 1987; 155: 72–8.

Ponzetto A. , Cote P. , Popper H. . Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Nat Acad Sci USA 1984; 81: 2208–12.

Roggendorf M. , Gmelin K. , Zoulek G. . Epidemiological studies on the prevalence of hepatitis delta virus infections in the Federal Republic of Germany. J Hepatol 1986; 2: 230–6.

Nordenfeldt E. , Al-Kandari S. , Hansson B. . Non-A, non-B and delta hepatitis in Kuwait. In: Vyas G. , Dienstag J. , Hoofnagle J.H. , eds. Proceedings of the 1984 International Symposium on Viral Hepatitis. Orlando: Grune and Stratton, 1984; 617.

Ponzetto A. , Forzani B. , Shuja Shafi M. Delta agent infection in Saudi Arabia – A general population study. In: Vyas G. , Dienstag J. , Hoofnagle J.H. , eds. Proceedings of the 1984 International Symposium on Viral Hepatitis. Orlando: Grune and Stratton, 1984; 643.

Rizzetto M. , Canese M.G. , Gerin J.L. , Purcell R.H. The Delta agent. In: Overby L. , Deinhardt F. , Deinhardt J. , eds. Viral hepatitis – 2^nd International Max von Pettenkofer Symposium. New York: Marcel Dekker, 1983; 49–51.

Rizzetto M. , Hoyer D. , Purcell R. , Gerin J. Hepatitis delta virus infection. In: Vyas G. , Dienstag J. , Hoofnagle J.H. , eds. Proceedings of the 1984 International Symposium on Viral Hepatitis. Orlando: Grune and Stratton, 1984; 371–9.

Govindarjan S. , Lee S. , Tong M. . Prevalence of Delta agent among Chinese in Taiwan and Los Angeles. J Med Virol 1984; 14: 33–7.

Centers for Disease Control. Fulminant hepatitis B among parenteral drug abusers – Kentucky, California. MMWR 1984, 30: 76–7.

Centers for Disease Control. Delta Hepatitis - Massachusetts. MMWR 1984, 33: 493–4.

Navascues C.A. , Rodriguez M. , Sotorrio N.G. . Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 1995; 11: 1981–4.

Gaeta G.B. , Stroffolini T. , Chiaramonte M. . Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 2000; 32: 824–7.

Shattock A.G. , Morgan M.B. Sensitive enzyme immunoassay for the detection of delta antigen and anti-delta, using serum as the delta antigen source. J Med Virol 1984; 13: 73–82.

Niro G.A. , Smedile A. , Andriulli A. , Rizzetto M. , Gerin J.L. , Casey J.L. Predominance of hepatitis delta virus genotype 1 among chronically infected Italian patients. Hepatology 1997; 25: 728–34.

Dentico P. , Baldi L. , Buongiorno R. , Pastore G. , Trotta F. , Schiraldi O. Prevalence of delta infection in hemodialysis units of southern Italy. In: Verme G. , Bonino F. , Rizzetto M. , eds. Viral hepatitis and Delta infection. New York: Alan R. Liss, Inc., 1983; 257.

Kharsa G. , Degott C. , Degos F. , Carnot F. , Potent F. , Kreis H. Fulminant hepatitis in renal transplant recipients. Transplantation 1987; 44: 221–3.

Pol S. , Dubois F. , Mattlinger B. . Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in France. Transplantation 1992; 54: 1096–7.

Rezvan H. , Forouzandeh B. , Taroyan S. , Fadaiee S. , Azordegan F. A study on delta virus infection and its clinical impact in Iran. Infection 1990; 18: 26–8.

Lettau L.A. , Alfred H.J. , Glew R.H. . Nosocomial transmission of delta hepatitis. Ann Intern Med 1986; 104: 631–5.

Marinucci G. , Valeri L. , DiGiacomo C. , Morganti D. Spread of delta infection in a group of haemodialysis carriers of HBsAg. In: Verme G. , Bonino F. , Rizzetto M. , eds. Viral hepatitis and Delta infection. New York: Alan R. Liss, Inc.; 1983: 151–4.

Gmelin K. , Roggendorf M. , Schlipkoter U. . Delta infection in a hemodialyzed patient. J Infect Dis 1985, 151: 374.

Update: Universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus and other blood-borne pathogens in healthcare settings. MMWR 1988; 37: 377–82.

Kellerman S. , Alter M.J. Preventing hepatitis and hepatitis C virus infection in endstage renal disease patients: back to basics. Hepatology 1999; 29: 291–3.

Thomas H.C. , Farci P. , Shein R. . Inhibition of hepatitis delta virus replication by lymphoblastoid human alpha interferon. Prog Clin Biol Res 1987; 234: 277–90.

Hoofnagle H.J. , Mullen K. , Peters M. . Treatment of chronic delta hepatitis with recombinant human alpha interferon. Prog Clin Biol Res 1987; 234: 291–8.

Rosina F. , Saracco G. , Latorre V. . Alpha 2 recombinant interferon in the treatment of chronic delta virus (HDV) hepatitis. Prog Clin Biol Res 1987; 234: 299–303.

Porres J.C. , Carreno V. , Bartholome J. , Moreno E. , Galiana V. , Quiroga J.A. Treatment of chronic delta infection with recombinant human interferon alfa 2c at high doses. J Hepatol 1989; 9: 338–50.

Rosina F. , Pintus C. , Meschievitz C. , Rizzetto M. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study. Hepatology 1991; 13: 1052–6.

Farci P. , Mandas A. , Coiana A. . Treatment of chronic hepatitis D with interferon alfa-2a. N Engl J Med 1994; 330: 88–94.

Di Marco V. , Giacchino R. , Timitilli A. . Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicenter study. J Viral Hepat 1996; 3: 123–8.

Hadziyannis S.J. Use of alpha-interferon in the treatment of chronic delta hepatitis. J Hepatol 1991; 13(Suppl 1): S21–6.

Di Bisceglie A.M. , Martin P. , Lisker-Melman M. . Therapy of chronic delta hepatitis with interferon-alfa 2b. J Hepatol 1990; 11(Suppl 1): S151–4.

Battegay M. , Simpson L.H. , Hoofnagle J.H. , Sallie R. , Di Bisceglie A.M. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis. J Med Virol 1994; 44: 389–92.

Lau D.T.Y. , Kleiner D.E. , Park Y. , Di Bisceglie A.M. , Hoofnagle J.H. Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. Gastroenterology 1999; 117: 1229–33.

Doong S.L. , Tsai C.H. , Schinazi R.F. , Liotta D.C. , Cheng Y.C. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′ – dideoxy-3'-thiacytidine and related analogues. Proc Natl Acad Sci USA 1991; 88: 8495–9.

Garripoli A. , Di Marco V. , Cozzolongo R. . Ribavirin for chronic hepatitis D: a pilot study. Liver 1994; 14: 154–7.

Arrigoni A. , Ponzetto A. , Actis G. , Bonino P. Levamisole and chronic delta hepatitis. Ann Intern Med 1983; 98: 1024.

Korba B.E. In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res 1996; 29: 49–51.

Colacino J.M. , Staschke K.A. The identification and development of antiviral agents for the treatment of chronic hepatitis B virus infection. Prog Drug Res 1998; 50: 259–322.